Gyre Therapeutics Inc.
Last updated September 27, 2026
Organization details
- Legal name
- Gyre Therapeutics Inc.
- Ownership
- Public
- Status
- Active
- Headquarters country
- United States
- Ticker symbol
- GYRE
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001124105
Board of directors
-
Andrea Hunt · DirectorSince 2023
-
Augustine Lawlor · DirectorSince 2023
-
Charles C. Wu · Director · Chief Executive OfficerSince 2023
-
David M. Epstein · DirectorSince 2024
-
Gordon Carmichael · DirectorSince 2023
-
Han Ying · Director · Chief Executive OfficerSince 2023
-
Nassim Usman · Director · President & CEOSince 2023
-
Ping Zhang · DirectorSince 2025
-
Renate Parry · DirectorSince 2023
-
Rodney L. Nussbaum · DirectorSince 2024
-
Songjiang Ma · Director · PresidentSince 2023
-
Thomas Wilson Eastling · DirectorSince 2022
-
Ying Luo · DirectorSince 2022
Chief executives
Han Ying
· Chief Executive Officer
Dates unknown
Charles C. Wu
· Chief Executive Officer
Since October 2023
Nassim Usman
· President & CEO
Until October 2023
· Former
Board connections
1 of this board's directors also sit on 1 other board.
- via David M. Epstein
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $0
- 0 sales by 0 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 21, 2025 | Songjiang Ma Director, Officer (President) | Open-market sale | −174 | $10.00 | $1,740 |
| Mar 20, 2025 | Songjiang Ma Director, Officer (President) | Open-market sale | −2,000 | $10.09 | $20,180 |
| Mar 19, 2025 | Songjiang Ma Director, Officer (President) | Open-market sale | −2,000 | $10.13 | $20,260 |
| Mar 18, 2025 | Songjiang Ma Director, Officer (President) | Open-market sale | −242 | $10.24 | $2,478 |
| Mar 17, 2025 | Songjiang Ma Director, Officer (President) | Open-market sale | −2,000 | $12.09 | $24,180 |
| Mar 14, 2025 | Songjiang Ma Director, Officer (President) | Open-market sale | −2,000 | $12.31 | $24,620 |
| Mar 13, 2025 | Songjiang Ma Director, Officer (President) | Open-market sale | −2,000 | $11.80 | $23,600 |
| Mar 12, 2025 | Songjiang Ma Director, Officer (President) | Open-market sale | −2,000 | $11.74 | $23,480 |
| Mar 11, 2025 | Songjiang Ma Director, Officer (President) | Open-market sale | −2,000 | $11.40 | $22,800 |
| Mar 10, 2025 | Songjiang Ma Director, Officer (President) | Open-market sale | −2,000 | $10.14 | $20,280 |
| Mar 7, 2025 | Songjiang Ma Director, Officer (President) | Open-market sale | −53 | $13.03 | $691 |
| Mar 7, 2025 | Songjiang Ma Director, Officer (President) | Open-market sale | −41 | $12.14 | $498 |
| Mar 7, 2025 | Songjiang Ma Director, Officer (President) | Open-market sale | −1,906 | $10.13 | $19,308 |
| Mar 6, 2025 | Songjiang Ma Director, Officer (President) | Open-market sale | −2,000 | $10.80 | $21,600 |
| Mar 5, 2025 | Songjiang Ma Director, Officer (President) | Open-market sale | −2,000 | $10.98 | $21,960 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.